Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung
- 15 February 1991
- Vol. 67 (4) , 892-895
- https://doi.org/10.1002/1097-0142(19910215)67:4<892::aid-cncr2820670406>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatinCancer, 1990
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?Cancer, 1989
- Treatment of advanced non‐small cell lung cancer with cisplatin, 5‐fluorouracil, and mitomycin CCancer, 1988
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987
- A New International Staging System for Lung CancerChest, 1986
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancerThe American Journal of Surgery, 1982
- Methotrexate compared with placebo in lung cancerCancer, 1977